Good morning. I am requesting round 2 of feedback on the word count, except this time it's more formal.
Today's word count is a beautiful and efficient 529 words, ~3 minutes.
The collective stock prices of the largest health care companies have recovered pretty much all of their losses from April, when analysts and algorithms soured on the industry over fears of "Medicare for All" and other looming changes.
The bottom line: The health care industry is still extremely profitable, and Wall Street has the attention span of a gnat, Axios' Bob Herman writes.
Sen. Ted Cruz and Rep. Alexandria Ocasio-Cortez appear to agree that birth control should be available over the counter.
Reality check: Experts say this would be the FDA's call. And the thornier issue is whether insurance would cover it if such a change is made.
What we're watching: Other Democrats also jumped into the Twitter conversation to tell Cruz that they're introducing over-the-counter birth control legislation. "We'd all love to have your support," Sen. Patty Murray tweeted.
A Florida-based company that sells short-term insurance plans has been sued by 2 patients who claim they were misled about what kind of coverage they were getting, NYT reports.
The plaintiffs are seeking class-action status and estimate that up to 500,000 people may have bought the plans.
This is what critics feared when the administration expanded short-term plans, which aren't required to cover a comprehensive set of benefits and can leave patients vulnerable if they get sick.
Photo: Eva Hambach/AFP/Getty Images
A top member of the House Oversight Committee sent a letter to Juul last week asking for a vast amount of internal records, the Daily Beast reports.
Why it matters: The letter contains "political heft as he can put the weight and resources of the subcommittee he heads behind getting answers from the vaping giant," the Daily Beast writes.
Dassault Systemes, a French maker of industrial software and technology, is buying New York-based health data provider Medidata in a deal worth $5.8 billion, Bob writes.
The bottom line: Medidata registered a $52 million profit last year on $636 million of revenue, but Dassault is betting that more pharmaceutical and medical device companies will use Medidata's software to help their products clear clinical trials.